JUVENESCENCE
Juvenescence Limited is a British Virgin Islands-based holding company that invests in human aging and longevity. Juvenescence has raised $111M to build an ecosystem and pipeline of assets targeting aging, age-related disease, and regeneration. Juvenescence believes that recent scientific and medical advances will enable the development of therapeutics that meaningfully extend human healthspan and eventually lifespan. A meaningful increase in lifespan in the already aging world will have profoun... d implications on all sectors of society, and in particular healthcare, education, insurance, and leisure. The company creates and partners with new companies with longevity-related therapeutics, by in-licensing compounds from academia and industry, or forming joint ventures with the foremost longevity scientists and leading research institutions. Their work is based on a novel scientific understanding of the underlying biological causes of aging, to create evidence-based therapeutics that can treat diseases of aging. Juvenescence's goal is to extend both lifespan and healthspan, by developing therapeutics that slow aging and promote juvenescence.
JUVENESCENCE
Social Links:
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2016-01-01
Status:
Active
Contact:
441624639396
Total Funding:
219.2 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail Microsoft Azure DNS Amazon Oregon Region CSC Global DNS
Similar Organizations
Arctoris
Arctoris is a tech-enabled platform company in biotechnology, combining robotics & data science to accelerate drug discovery.
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Eidos Therapeutics
Eidos Therapeutics is a clinical-stage biotech company developing novel, genetically targeted therapies to improve the lives of patients.
KSQ Therapeutics
KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Sirnaomics
Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.
Ultivue
Ultivue is a biotechnology company that specializes in tissue imaging, diagnostics, and multiplexing.
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-03-04 | Portage Pharmaceuticals | Portage Pharmaceuticals acquired by Juvenescence | N/A |
Investors List
Longevity Vision Fund
Longevity Vision Fund investment in Series B - Juvenescence
Grok Ventures
Grok Ventures investment in Series B - Juvenescence
IPGL
IPGL investment in Series B - Juvenescence
Explorer Equity Group
Explorer Equity Group investment in Series B - Juvenescence
Oryx Ventures
Oryx Ventures investment in Series B - Juvenescence
Kingsley Advani
Kingsley Advani investment in Series B - Juvenescence
Formic Ventures
Formic Ventures investment in Series B - Juvenescence
Andrew Banks
Andrew Banks investment in Seed Round - Juvenescence
Apeiron Investment Group
Apeiron Investment Group investment in Seed Round - Juvenescence
Karim Hakimzadeh
Karim Hakimzadeh investment in Seed Round - Juvenescence
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-03-21 | MDI Therapeutics | Juvenescence investment in Series A - MDI Therapeutics | 9 M USD |
| 2020-12-30 | LyGenesis | Juvenescence investment in Convertible Note - LyGenesis | 11 M USD |
| 2019-10-21 | LyGenesis | Juvenescence investment in Debt Financing - LyGenesis | 4 M USD |
| 2019-05-28 | Souvien Therapeutics | Juvenescence investment in Venture Round - Souvien Therapeutics | 3.5 M USD |
| 2019-03-27 | BYOMass | Juvenescence investment in Venture Round - BYOMass | 1.5 M USD |
| 2019-02-04 | BHB Therapeutics | Juvenescence investment in Venture Round - BHB Therapeutics | 3 M USD |
| 2018-09-04 | AgeX Therapeutics | Juvenescence investment in Private Equity Round - AgeX Therapeutics | 43.2 M USD |
| 2018-08-06 | Napa Therapeutics | Juvenescence investment in Venture Round - Napa Therapeutics | 3 M USD |
| 2018-07-12 | FoxBio | Juvenescence investment in Venture Round - FoxBio | 10 M USD |
| 2018-06-18 | Insilico Medicine | Juvenescence investment in Series A - Insilico Medicine | 6 M USD |
More informations about "Juvenescence"
Juvenescence - Crunchbase Investor Profile & Investments
Juvenescence Limited is a British Virgin Islands-based holding company that invests in human aging and longevity. Juvenescence has raised $111M to build an ecosystem and pipeline of …See details»
Our Pipeline - Juvenescence
CORE MEDICINES PIPELINE Leading Healthspan Innovations Our core medicines (JuvTherapeutics) are comprised of therapeutics developed by the Juvenescence team, targeting fundamental aging mechanisms with a near-term age-related first indication identified for …See details»
Juvenescence Company Profile 2024: Valuation, …
Juvenescence General Information Description. Developer of medical therapies designed to treat diseases of aging and increase human longevity. The company's therapies focus on healthy aging and lifestyle, keto diet, metabolic …See details»
Science - Juvenescence
SCIENTIFIC APPROACH What Causes Aging? We base our work on breakthrough scientific discoveries that target the underlying biological causes of aging. 85% of older adults have at least one chronic health condition, and …See details»
Juvenescence - Funding, Financials, Valuation & Investors
Juvenescence is a biotech company that develops therapies and products to modify aging and help people live longer. Search Crunchbase. Start Free Trial . Chrome Extension. ... How …See details»
Juvenescence - Org Chart, Teams, Culture & Jobs | The Org
View Juvenescence's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Juvenescence: Think aging up, rather than disease down
May 24, 2023 Juvenescence was founded from a passion for healthspan intervention; we’re narrating, and, hopefully, providing real clarity and coherence for potential investors about why we’re doing what we’re doing, how …See details»
Jeff M Bio - Juvenescence
Jeff Madwed, PhD is currently Executive Director of the JuvRx Division at Juvenescence, a healthcare organization focused on developing products for healthy aging. Jeff is an …See details»
Juvenescence: from strength to strength in R&D and …
Jan 1, 2021 Continuing our series of interviews with our Advisory Panel members, we spoke to Greg Bailey, CEO of biopharmaceutical company Juvenescence, who brought us up-to-speed on the company’s fundraise and …See details»
Juvenescence - Investments, Portfolio & Company Exits
Juvenescence has acquired Portage Pharmaceuticals on Mar 4, 2021. Unlock for free . Investments. Edit Investments Section. Number of Investments 14. Number of Lead …See details»
All Centres - Juvenescence
[email protected]. Learn More. Monsignor J.S. Smith. 2919 Douglasdale Blvd SE (587) 432-7734 Monday to Friday 7:00 AM – 6:00 PM. Closed on Stat Holidays . …See details»
Longevity supplements report: Juvenescence profile
Apr 7, 2021 Juvenescence was founded by three scientist/investors with long-proven track records in healthcare market: Chairman, Jim Mellon, is a Trustee at the Buck Institute for Research on Aging and author of the book, …See details»
Juvenescence raises $100M to fund longevity assets to early …
Aug 19, 2019 Juvenescence has raised $100 million (€90 million) to advance multiple anti-aging programs. The U.K. company, which was co-founded by Jim Mellon, has reeled in $165 million …See details»
Antoxerene Closes $10 Million Deal with Juvenescence to Develop …
This is a great fit with Juvenescence’s track record in drug development, so FoxBio is a very exciting new company in the area of longevity.” ... Ichor Therapeutics, Inc. is a premier, …See details»
Jim Mellon - Juvenescence
Jim MellonDeputy Chairman / Co-Founder Jim Mellon, a co-founder and Deputy Chairman of Juvenescence, was inspired by the possibilities and advances being made in the area of …See details»
Juvenescence (2): "It's all about prevention, and that's incredibly ...
Aug 14, 2020 Juvenescence’s Greg Bailey on democratising healthcare, paradigm shifts and disruptive technologies. Yesterday we published the first part of our interview with Greg Bailey, …See details»
Team behind the scenes - Juvenescence
My role at Juvenescence is managing camps, enrollment, and accounts, all with a focus on delivering the best service we can to our families. Show Less. Ashley Vay LISA CRAIK Ashley …See details»
Juvenescence - Crunchbase Company Profile & Funding
Juvenescence is a non-profit organization that provides child care, summer camps, programs, and support services. Calgary, Alberta, Canada; 11-50; Private; juvenescence.ca/ 1,292,061; ...See details»
General FAQs - Juvenescence
Juvenescence is closed for all Statutory Holidays or the next business day if it lands on the weekend. ADDITIONALLY: Monsignor Smith, Our Lady of the Rosary, St. Benedict and …See details»
Juvenescence: Investing in the age of longevity
Juvenescence: Investing in the age of longevity. Author: Jim Mellon and Al Chalabi. Editor’s note: This new book by Jim Mellon and Al Chalabi is a layman’s guide to longevity. It investigates …See details»